NO984491L - SCF-analogpreparater og fremgangsmÕte for fremstilling av disse - Google Patents

SCF-analogpreparater og fremgangsmÕte for fremstilling av disse

Info

Publication number
NO984491L
NO984491L NO984491A NO984491A NO984491L NO 984491 L NO984491 L NO 984491L NO 984491 A NO984491 A NO 984491A NO 984491 A NO984491 A NO 984491A NO 984491 L NO984491 L NO 984491L
Authority
NO
Norway
Prior art keywords
methods
preparation
analog preparations
scf analog
stem cell
Prior art date
Application number
NO984491A
Other languages
English (en)
Norwegian (no)
Other versions
NO984491D0 (no
Inventor
Hsieng Sen Lu
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of NO984491D0 publication Critical patent/NO984491D0/no
Publication of NO984491L publication Critical patent/NO984491L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
NO984491A 1996-04-05 1998-09-25 SCF-analogpreparater og fremgangsmÕte for fremstilling av disse NO984491L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/628,428 US5885962A (en) 1996-04-05 1996-04-05 Stem cell factor analog compositions and method
PCT/US1997/005541 WO1997038101A1 (fr) 1996-04-05 1997-04-03 Compositions d'analogues de scf et procedes associes

Publications (2)

Publication Number Publication Date
NO984491D0 NO984491D0 (no) 1998-09-25
NO984491L true NO984491L (no) 1998-10-05

Family

ID=24518837

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984491A NO984491L (no) 1996-04-05 1998-09-25 SCF-analogpreparater og fremgangsmÕte for fremstilling av disse

Country Status (17)

Country Link
US (1) US5885962A (fr)
EP (1) EP0904367B1 (fr)
JP (1) JP4066388B2 (fr)
KR (1) KR20000004951A (fr)
CN (1) CN1214734A (fr)
AT (1) ATE363488T1 (fr)
AU (1) AU726663B2 (fr)
BR (1) BR9708578A (fr)
CA (1) CA2249181C (fr)
CZ (1) CZ301598A3 (fr)
DE (1) DE69737766T2 (fr)
ES (1) ES2286830T3 (fr)
IL (1) IL126221A0 (fr)
NO (1) NO984491L (fr)
SK (1) SK131098A3 (fr)
WO (1) WO1997038101A1 (fr)
YU (1) YU41798A (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0789761T3 (da) * 1994-11-04 2005-11-28 Applied Research Systems Human SCF, en splejsningsvariant deraf, dens farmaceutiske anvendelse
US5969105A (en) * 1996-10-25 1999-10-19 Feng; Yiqing Stem cell factor receptor agonists
US6967092B1 (en) 1996-10-25 2005-11-22 Mc Kearn John P Multi-functional chimeric hematopoietic receptor agonists
US6291661B1 (en) 1998-07-02 2001-09-18 Immunex Corporation flt3-L mutants and method of use
MXPA02000525A (es) * 1999-07-15 2005-07-01 Inst Genetics Llc Formulaciones de il-11.
JP2003518929A (ja) * 1999-12-23 2003-06-17 ユニヴェルシテ・ドゥ・ジュネーブ 基底側部選別シグナル、およびその阻害物質
WO2003049693A2 (fr) * 2001-12-06 2003-06-19 Wyeth Procede et composition permettant d'induire une perte de poids
US7439063B2 (en) * 2002-06-11 2008-10-21 Burnham Institute For Medical Research Neuroprotective synergy of erythropoietin and insulin-like growth factors
US20150018408A1 (en) 2013-07-10 2015-01-15 The Regents Of The University Of Michigan Therapeutic antibodies and uses thereof
AU2012205718B2 (en) * 2011-01-10 2017-07-06 The Regents Of The University Of Michigan Stem cell factor inhibitor
US20150196622A1 (en) * 2012-08-21 2015-07-16 Ali Nayer Materials and methods for modulating glucose uptake
CN105985424B (zh) * 2015-01-30 2019-08-23 苏州方舟生物医药有限公司 一种干细胞因子功能性肽段及其应用
WO2016187820A1 (fr) * 2015-05-26 2016-12-01 中国科学院广州生物医药与健康研究院 Milieu de culture de cellule primaire humaine et son utilisation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
JP2657113B2 (ja) * 1989-10-16 1997-09-24 アムジエン・インコーポレーテツド 幹細胞因子
DK0423980T3 (da) * 1989-10-16 2000-10-09 Amgen Inc Stamcellefaktor
WO1992000376A1 (fr) * 1990-06-25 1992-01-09 Immunex Corporation Facteur de croissance de mastocytes
US20030125519A1 (en) * 1990-08-27 2003-07-03 Peter Besmer Ligand for the c-kit receptor and methods of use thereof
DE4224050A1 (de) * 1991-07-31 1993-02-04 Hoffmann La Roche Loesliche kit-liganden
US5525708A (en) * 1994-03-28 1996-06-11 Cytomed, Inc. Covalent dimer of kit ligand

Also Published As

Publication number Publication date
SK131098A3 (en) 1999-03-12
BR9708578A (pt) 1999-08-03
CZ301598A3 (cs) 1999-01-13
KR20000004951A (ko) 2000-01-25
CN1214734A (zh) 1999-04-21
DE69737766T2 (de) 2007-10-11
ES2286830T3 (es) 2007-12-01
ATE363488T1 (de) 2007-06-15
CA2249181C (fr) 2009-11-17
JP4066388B2 (ja) 2008-03-26
EP0904367B1 (fr) 2007-05-30
WO1997038101A1 (fr) 1997-10-16
CA2249181A1 (fr) 1997-10-16
AU2606497A (en) 1997-10-29
YU41798A (sh) 1999-07-28
NO984491D0 (no) 1998-09-25
EP0904367A1 (fr) 1999-03-31
IL126221A0 (en) 1999-05-09
AU726663B2 (en) 2000-11-16
JP2000508170A (ja) 2000-07-04
US5885962A (en) 1999-03-23
DE69737766D1 (de) 2007-07-12

Similar Documents

Publication Publication Date Title
EP0653940A4 (fr) Facteurs mitogenes gliaux, leur preparation et utilisation.
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
WO2000075350A3 (fr) Sequences d'acide nucleique codant des proteines impliquees dans la beta-oxydation des acides gras et procedes d'utilisation
AR006188A1 (es) "composicion farmaceutica para inhibir la actividad de serinproteasa, metodo in vitro para inhibir la actividad de serinproteasa y metodo para preparar dicha composicion".
NO984491L (no) SCF-analogpreparater og fremgangsmÕte for fremstilling av disse
GB9902660D0 (en) Plant gene
HUP0000302A2 (hu) OB fúziós protein készítmények és módszerek
DE68927344D1 (de) Hefezellen der Gattung-Schwanniomyces
DK572487A (da) Fremgangsmaade til fremstilling af human vaekstfaktor fra endotheliale celler
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
CA2267670A1 (fr) Methode pour preparer des cellules humaines a facteur souches polypeptide
IL142905A0 (en) Functional antagonists of hedgehog activity
WO2002097038A3 (fr) Proteines hybrides beta-1 de chimiokine
NO20013608L (no) DNA-klon for human vevsfaktorinhibitor
BR0009393A (pt) Polipeptìdeo, sequência de ácido nucleico isolada, construção de ácido nucleico, vetor de expressão recombinante, célula hospedeira recombinante, método para a produção do polipeptìdeo, uso de um polipeptìdeo, e, composição detergente
GB9722320D0 (en) Human cell cycle checkpoint proteins
EE200000152A (et) Aminoterminaalselt kärbitud MCP-2 vormid, DNA molekulid, ekspressioonivektor, peremeesrakk, rekombinantne meetod proteiini valmistamiseks, proteiini kasutamine ning farmatseutiline kompositsioon
WO1997026322A3 (fr) Compositions et procedes d'inhibition de l'hexokinase
DK11187D0 (da) Dna-sekvenser der koder for proteiner med husi-type i inhibitorers biologiske aktivitet, biotekniske fremgangsmaader til fremstilling af proteinerne o g farmaceutiske praeparater der indeholder dem
IE871871L (en) Cloning and expression of acidic fibroblast growth factor
LTIP610A (en) Inhibitors of cells proliferation, pharmaceutical composition and method for preparation of compounds
NZ335633A (en) Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases
CA2002833A1 (fr) Proteines de liaison de l'interferon gamma
EP0204302A3 (fr) Laminine et sa préparation
ES8801316A1 (es) Un procedimiento para preparar un material peptidico que tiene actividad humoral timica